Low expression of death receptor 4 (DR4; TRAILR1; CD261) has been linked to poor prognosis in CRC [200], consistent with a tumour suppressor role for DR4 and its ligand, tumour necrosis factor related apoptosis-inducing ligand (TRAIL). Here, TNFRSF10A is linked to colorectal carcinoma.